For Immediate Release
For more information contact:
Feinstein Kean Healthcare
Accelerated Cure Project Reaches Half Way Mark in Building MS Repository, World's Largest Open Access Biobank for Multiple Sclerosis Research
Organization has collected 500 blood and tissue samples for MS Research
(Waltham, MA July 16, 2007) The Accelerated Cure Project for MS, a national nonprofit organization, today announced that in they have reached the half way mark in their drive to collect blood samples and data from 1,000 subjects across the country. After reaching the 1,000 subject milestone, the Accelerated Cure Project intends to continue collecting samples from as many as 10,000 subjects for its MS Respository. The repository is projected to become the largest openly accessible, multi-disciplinary collection of bio-samples ever assembled for use in Multiple Sclerosis (MS) research.
This is a major milestone for the Accelerated Cure Project, says Art Mellor, founder and CEO. Limited sample size is one of the most frequently cited reasons for inconclusive results in MS research. The repository lets us provide researchers with immediate access to a far greater number of samples than most scientists could collect themselves.
In addition to helping researchers overcome the obstacle of limited sample size, this repository will provide a common population of samples useful in a wide variety of disciplines, which will enable results from different research perspectives to be easily combined and correlated.
Subjects enrolled in the study will be followed over time to allow new samples to be taken and to record important changes in clinical status. Studying the same sample population over time, and pooling knowledge in a central database, is seen as a major step toward understanding what causes MS, thereby accelerating a cure for the nearly 2 million people worldwide afflicted with this disease.
About Accelerated Cure Project
Accelerated Cure Project for MS (ACP) is a nonprofit organization whose mission is to accelerate efforts toward a cure for multiple sclerosis (MS) by rapidly advancing research that determines its causes and mechanisms. We provide biomedical researchers with resources that catalyze open scientific collaboration and enable them to explore their novel research ideas rapidly and cost-efficiently. ACP’s strategic initiatives include the Multiple Sclerosis Discovery Forum and the ACP Repository, a large-scale collection of highly-characterized biosamples available to scientists at any organization conducting research that contributes to our mission. All results generated through analysis of Repository samples and data are contributed back to the ACP Repository Database, resulting in an increasingly valuable and comprehensive information resource that can be analyzed to reveal new insights about MS. To date, ACP has enrolled almost 3,000 participants into the Repository through a network of 10 MS clinical centers across the United States. The samples provided by people with MS and related disorders have supported more than 60 research studies worldwide and generated more than 150 million returned data points.
About Multiple Sclerosis
Multiple Sclerosis is a chronic demyelinating disorder of the central nervous system that often results in severe disability including the inability to walk, blindness, cognitive dysfunction, extreme fatigue, and other serious symptoms. MS affects more than 400,000 people in the US and two million individuals worldwide. The disorder occurs twice as often in women as in men. What causes MS is undetermined and no cure has yet been developed.